Related Experiment Video
Updated: May 9, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis
K Evangelou1, J Bartkova, A Kotsinas
1Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, University of Athens, Athens, Greece.
Abstract:
Oncogenic stimuli trigger the DNA damage response (DDR) and induction of the alternative reading frame (ARF) tumor suppressor, both of which can activate the p53 pathway and provide intrinsic barriers to tumor progression. However, the respective timeframes and signal thresholds for ARF induction and DDR activation during tumorigenesis remain elusive. Here, these issues were addressed by analyses of mouse models of urinary bladder, colon, pancreatic and skin premalignant and malignant lesions. Consistently, ARF expression occurred at a later stage of tumor progression than activation of the DDR or p16(INK4A), a tumor-suppressor gene overlapping with ARF. Analogous results were obtained in several human clinical settings, including early and progressive lesions of the urinary bladder, head and neck, skin and pancreas. Mechanistic analyses of epithelial and fibroblast cell models exposed to various oncogenes showed that the delayed upregulation of ARF reflected a requirement for a higher, transcriptionally based threshold of oncogenic stress, elicited by at least two oncogenic 'hits', compared with lower activation threshold for DDR. We propose that relative to DDR activation, ARF provides a complementary and delayed barrier to tumor development, responding to more robust stimuli of escalating oncogenic overload.
Insights
The alternative reading frame (ARF) tumor suppressor is activated later than the DNA damage response (DDR) during cancer progression. ARF acts as a delayed barrier against tumor development, requiring higher oncogenic stress signals than DDR.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Oncogenic stimuli activate the DNA damage response (DDR) and alternative reading frame (ARF) tumor suppressor.
- Both pathways can activate the p53 pathway, a critical barrier to tumor progression.
- The timing and signal thresholds for ARF induction versus DDR activation during tumorigenesis are not well understood.
Purpose of the Study:
- To investigate the temporal relationship and signal thresholds for ARF induction and DDR activation during tumorigenesis.
- To compare these events in various preclinical and clinical cancer models.
Main Methods:
- Analysis of mouse models of premalignant and malignant lesions in the urinary bladder, colon, pancreas, and skin.
- Examination of human clinical samples from early and progressive lesions of the urinary bladder, head and neck, skin, and pancreas.
- Mechanistic studies using epithelial and fibroblast cell models exposed to oncogenes.
Main Results:
- ARF expression consistently occurred at later stages of tumor progression than DDR activation or p16(INK4A) induction across all models.
- Similar temporal patterns were observed in human cancer lesions.
- Mechanistic studies revealed that ARF upregulation requires a higher oncogenic stress threshold (at least two oncogenic 'hits') compared to DDR activation.
Conclusions:
- ARF induction is a delayed event in tumorigenesis relative to DDR activation.
- ARF functions as a complementary, delayed barrier to tumor development, responding to more significant oncogenic stress.
- This suggests a stepwise model of tumor suppression involving distinct responses to escalating oncogenic stimuli.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

